Chief Executive Officer, Neuropsychiatric Precision Medicine Development Company

TDL Discovery Group
Job Location
Redwood City
Redwood City, CA 94061
$240,000 - $460,000

Stock options, performance bonus stock options, Medical, Dental, 401K.

Job Description

Candidate will lead the financing and advanced development of second-generation precision medicine testing in neuropsychiatry and pain management. 


Experience in venture capital financing and in fund raising through strategic partnerships.   In depth knowledge of the genetics of pharmaceutical drug response in psychiatry and pain management.  Ability to develop and manage clinical confirmatory studies of precision medicine genetic tests. General knowledge of new drug development in psychiatry and pain management.  Knowledge of  FDA, international and state regulations for laboratory developed tests and for genetic tests designed to be sold "direct-to-the consumer.  Knowledge of Delaware corporate law, securities regulations, and licensing and contract law. Understanding of Medicare, Medicaid and private payor reimbursement.

How to Apply

Email resume to   Call 415 533-5696 for more information.

About Our Organization

TDL Discovery is the private parent organization of two early-stage development companies--a precision medicine development company and a digital health development company.  The precision medicine company is focusing on new, breakthrough discoveries for advanced, second generation precision medicine genetic testing.  The digital health development company is applying existing technologies to behavioral health patient monitoring and coaching.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.